Previous studies showed that miR-126 expression inhibits tumor cell proliferation, invasion, and the epithelial–mesenchymal transition (EMT) process by targeting oncogenic genes such as v-crk avian sarcoma virus CT10 oncogene homolog (CRK) [23,24,25]. This evidence concerns the gene CRK and neoplasm.